PLYANZE
Dead / Abandoned — Abandoned — no statement of use filed (as of 05 Jan 2026)
What this means for you
This application is over — abandoned 05 Jan 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97395933
- Mark type
- Stylized text
- Filed
- 05 May 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 05 Jan 2026
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Owner
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
- Janssen Sciences Ireland Unlimited Company, Ringaskiddy, Co. Cork, IE
Prosecution history
- 05 Jan 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 05 Jan 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 06 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2025 — SOU EXTENSION 4 GRANTED
- 05 May 2025 — SOU EXTENSION 4 FILED
- 05 May 2025 — SOU TEAS EXTENSION RECEIVED
- 29 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2024 — SOU EXTENSION 3 GRANTED
- 29 Oct 2024 — SOU EXTENSION 3 FILED
- 29 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 21 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 May 2024 — SOU EXTENSION 2 GRANTED
- 20 May 2024 — SOU EXTENSION 2 FILED
- 20 May 2024 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED